Pharmaceutical efficacy of novel human-origin Faecalibacterium prausnitzii strains on high-fat-diet-induced obesity and associated metabolic disorders in mice

The pharmacological effects of the F. prausnitzii strains were evaluated using a 12-week high-fat diet (HFD)-induced mouse model. This study aimed to find the alteration of gut microbiota composition after F. parusnitzii supplementation.